What one share of Pacira BioSciences holds
We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. and in April 2019, we changed our name to Pacira BioSciences, Inc.
Pacira BioSciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $17.58 |
|---|---|
| Profit | $0.34 |
| Capex (buildings and equipment) | $0.19 |
| Free cash flow | $4.23 |
| Cash and investments | $5.17 |
| Debt | $9.12 |
| Book value | $16.87 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $26.18 | −$55.32 | $9.61 | −$45.97 | — | −$40.04 |
| 2010 | $25.37 | −$47.29 | $11.79 | −$55.13 | — | −$84.29 |
| 2011 | $0.95 | −$2.64 | $0.38 | −$2.26 | — | $1.90 |
| 2012 | $1.29 | −$1.72 | $0.60 | −$2.91 | — | $2.02 |
| 2013 | $2.58 | −$1.93 | $0.37 | −$1.69 | — | $1.23 |
| 2014 | $5.60 | −$0.39 | $0.65 | $0.10 | — | $4.73 |
| 2015 | $6.03 | $0.04 | $0.98 | −$0.30 | — | $5.93 |
| 2016 | $7.42 | −$1.02 | $0.66 | $0.23 | — | $5.84 |
| 2017 | $7.20 | −$1.07 | $0.48 | −$0.04 | — | $6.87 |
| 2018 | $8.24 | −$0.01 | $0.35 | $0.84 | — | $7.79 |
| 2019 | $10.14 | −$0.27 | $0.24 | $1.45 | — | $8.47 |
| 2020 | $9.84 | $3.33 | $0.87 | $0.90 | — | $14.20 |
| 2021 | $11.87 | $0.92 | $1.01 | $1.75 | — | $16.33 |
| 2022 | $14.33 | $0.34 | $0.65 | $2.48 | — | $16.87 |
| 2023 | $12.99 | $0.91 | $0.29 | $2.68 | — | $18.72 |
| 2024 | $15.16 | −$2.15 | $0.23 | $3.87 | — | $16.83 |
| 2025 | $16.13 | $0.16 | $0.34 | $3.03 | — | $16.86 |
Common questions about Pacira BioSciences
How much does one share of Pacira BioSciences earn?
Over the last 12 months, each share of Pacira BioSciences earned $0.34 of profit on $17.58 of sales, keeping about 2¢ of every $1 (profit margin).
Does Pacira BioSciences pay a dividend?
Pacira BioSciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Pacira BioSciences’s book value per share?
Pacira BioSciences’s book value is $16.87 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Pacira BioSciences have?
Each share of Pacira BioSciences has $5.17 of cash and investments and $9.12 of debt, as of June 30, 2026.
What is Pacira BioSciences’s free cash flow per share?
$4.23 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Pacira BioSciences bought back shares?
Pacira BioSciences’s share count rose about 7759% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.